Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 482
Summary
- Conditions
- Biliary Tract Cancer
- Type
- Interventional
- Phase
- Phase 2Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: Treatment: protocol designed to evaluate one or more interventions for treating a disease, syndrome or conditionMasking: Double (Participant, Investigator)Primary Purpose: Treatment
Participation Requirements
- Age
- Younger than 125 years
- Gender
- Both males and females
Description
Part 1 of study(Phase 2) is planned to have 120 patients and anticipated completion on July 2019. Recruitment completed. Part 2 of study(Phase 3) is planned to have 350 patients and anticipated completion on Dec 2022. Not yet recruiting.
Part 1 of study(Phase 2) is planned to have 120 patients and anticipated completion on July 2019. Recruitment completed. Part 2 of study(Phase 3) is planned to have 350 patients and anticipated completion on Dec 2022. Not yet recruiting.
Tracking Information
- NCT #
- NCT03093870
- Collaborators
- Not Provided
- Investigators
- Not Provided
Get Well Soon